The Efficacy of Shinbaro for the Preventive Treatment of Migraine: A Pilot Study.

Yesol JungBohee WonMijung LeeJinyoung ChungSung Ju HanManho Kim

Published in: Evidence-based complementary and alternative medicine : eCAM (2019)

Shinbaro demonstrated prophylactic effects in migraine patients, significantly reducing their mean migraine frequency, rescue medications frequency, and the serum CGRP concentration after 12 weeks of treatment. This study is registered in Clinical Research Information Service, Seoul National University Hospital Clinical Research Institute (IRB No. 1604-138-758).

Keyphrases

mental health
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
gestational age